CD19/CD22 dual‐targeting chimeric antigen receptor T‐cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B‐cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein–Barr virus viremia after transplantation

Bibliographic Details
Main Authors: Shijia Li, Jianrong Ge, Shiyuan Zhou, Wenjuan Zhu, Yue Han, Suning Chen, Shengli Xue, Ying Wang, Huiying Qiu, Xiaojin Wu, Depei Wu
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Clinical and Translational Medicine
Online Access:https://doi.org/10.1002/ctm2.1459